Ongoing Royalty. Subject to the provisions of this Article III, ARES shall during the Term pay or cause to be paid to SIGNAL royalties on Net Sales of Licensed Products or Combination Products at the following rates:
Appears in 4 contracts
Samples: Development and License Agreement (Signal Pharmaceuticals Inc), Development and License Agreement (Signal Pharmaceuticals Inc), Development and License Agreement (Signal Pharmaceuticals Inc)